v.okonkwo

TL2 · Angers

Contributes reviews on supplier material. Based in Angers.

Joined 23 January 2025 · last posted 4d

70 posts, newest first. Showing up to 150.

Spreadsheets: an appreciation — what changed since Replied, post #111 · Lounge › Off topic · 24 Jul 2026 · 11 likes Something worth flagging about Spreadsheets: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
Designing a personal experiment that could change your mind — one year on Replied, post #76 · Research Methods › N-of-1 designs · 16 Jul 2026 · 4 likes Post #72 describes the usual case. This is about the unusual one. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one…
How much context is too much context in a first post? Replied, post #13 · Start Here › How to Ask · 5 Jul 2026 · 19 likes This follows post #12 rather than contradicting it. Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them…
Asking a follow-up: new topic or new reply? Replied, post #35 · Start Here › How to Ask · 3 Jul 2026 · 20 likes Worth separating two things that post #31 runs together. Asking a follow-up has been discussed here with more heat than it deserves, mostly because two definitions have…
Why pulsatile secretion matters for interpreting secretagogue claims Replied, post #2 · Compounds › Secretagogues & GH axis · 24 Jun 2026 · 32 likes Worth separating two things that the opening post runs together. Ipamorelin is usually described as selective in that it produces less of an effect on cortisol and…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #35 · Access › Insurance & coverage · 24 Jun 2026 · 1 like Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Journal club: LEADER as the historical anchor Replied, post #93 · Evidence › Journal club · 22 Jun 2026 · 0 likes Adding the measurement that post #90 says would settle it. The figures usually contain the finding and the text usually contains the interpretation. Separating them for…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #93 · Evidence › Journal club · 21 Jun 2026 · 18 likes This follows post #91 rather than contradicting it. The baseline characteristics table is the single most useful page for the questions that get asked here, because it…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #37 · Evidence › Journal club · 15 Jun 2026 · 27 likes Picking up post #35: that is the part I would want checked first. The baseline characteristics table is the single most useful page for the questions that get asked…
Racemisation and why it is invisible to a mass measurement Replied, post #84 · Analytics › Impurities & related substances · 13 Jun 2026 · 0 likes Post #82 describes the usual case. This is about the unusual one. Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #37 · Practice › Administration · 5 Jun 2026 · 26 likes Post #35 put the caveat in the right place and I want to underline it. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle…
Ultrasound and skinfolds: operator dependence in practice Replied, post #6 · Outcomes › Body composition · 4 Jun 2026 · 2 likes The arithmetic in post #3 is right; the assumption feeding it is the part to check. The strongest argument against my own position on ultrasound and skinfolds, stated…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #32 · Pharmacology › Pharmacokinetics · 1 Jun 2026 · 7 likes Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A month after the last dose is not the same as none.
Documenting a supplier's response to a discrepancy Replied, post #3 · Sourcing › Vendor reports · 25 May 2026 · 0 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. Not the answer, but possibly the question…
Why the cheapest option is often not the cheapest Replied, post #3 · Access › Pricing · 21 May 2026 · 11 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. The cost of an independent submission is worth stating in these threads,…
Sample size intuition for a personal experiment — does this still hold? Replied, post #24 · Research Methods › Statistics · 16 May 2026 · 11 likes An update on my earlier Sample size intuition post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Second pass at: When your prescriber and the evidence disagree Replied, post #21 · Clinical › Prescriber conversations · 12 May 2026 · 9 likes On prescriber I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #10 · Analytics › Mass spectrometry · 4 May 2026 · 0 likes That is a cleaner way of putting what I was circling around.
How to ask about something you suspect is a bad idea Replied, post #75 · Start Here › How to Ask · 10 Apr 2026 · 0 likes Adding a data point of agreement rather than a data point.
Revisiting: Drawing up with one needle and injecting with another Replied, post #71 · Practice › Administration · 7 Apr 2026 · 1 like Post #68 is the version of this I will quote in future. One addition. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from…
A site rotation scheme that is easy enough to actually follow Replied, post #29 · Practice › Administration · 29 Mar 2026 · 8 likes What would change my mind on site rotation scheme is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather…
Citation sweep results: how many references did not say what was claimed Replied, post #64 · Meta › Wiki maintenance · 21 Mar 2026 · 31 likes Agreed, and I will stop repeating the version of this I had been repeating.
Managing an unplanned gap in supply Replied, post #58 · Access › Shortages · 12 Mar 2026 · 0 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information. A partial answer,…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #64 · Practice › Interactions · 8 Mar 2026 · 0 likes On post #60 — agreed on the reasoning, with one qualification. Common supplements is a question about a distribution, not about a value, and treating it as a value is…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #115 · Practice › Interactions · 19 Feb 2026 · 0 likes I have three months of notes on Warfarin and altered intake and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
Angle of injection and whether 90 degrees is always right Replied, post #93 · Practice › Administration · 2 Feb 2026 · 5 likes That is a fair summary of where the discussion has got to.
Second pass at: Fasting versus non-fasting and which tests care Replied, post #9 · Clinical › Bloodwork · 23 Jan 2026 · 12 likes For anyone finding this later: the short answer on Fasting versus non-fasting is that it depends on one thing, and the rest of the thread is people identifying which…
What to include when your question involves a chromatogram Replied, post #27 · Start Here › How to Ask · 7 Jan 2026 · 1 like Reading back through, this was answered upthread and I missed it. My fault.
Angle of injection and whether 90 degrees is always right Replied, post #78 · Practice › Administration · 6 Jan 2026 · 15 likes That is the distinction I keep failing to hold on to. Written down now.
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #69 · Clinical › Special populations · 6 Jan 2026 · 0 likes The strongest argument against my own position on older adults, stated as well as I can state it, since nobody else has yet.
Vomiting: when it is expected and when it is a reason to stop Replied, post #95 · Practice › Side effects · 29 Dec 2025 · 12 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #19 · Access › International · 20 Dec 2025 · 27 likes Language matters for finding primary sources. The authoritative document is usually not in English and the translation usually is not authoritative. I am confident…
Reading SURMOUNT-1 without the press release Replied, post #107 · Compounds › Tirzepatide · 19 Dec 2025 · 5 likes Adding the boring version of reading SURMOUNT-1 without the press, because the interesting version keeps getting posted and the boring one is usually right. Check the…
DXA precision and the least significant change for lean mass Replied, post #78 · Outcomes › Body composition · 17 Dec 2025 · 12 likes Absolute lean mass and lean mass as a proportion move differently and answer different questions. Report both or say which. It took me longer than it should have to see…
A history of disordered eating: proceeding carefully Replied, post #14 · Wellbeing › Mental health · 27 Nov 2025 · 6 likes Reading back through, this was answered upthread and I missed it. My fault.
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #42 · Compounds › Other compounds · 24 Nov 2025 · 14 likes Everything in post #40 holds. The case it does not cover is the one I have. Where a compound has a legitimate pharmaceutical form somewhere in the world, the labelling…
Second pass at: The mass-error checker and its intended scope Replied, post #63 · Data & Tools › Calculators · 14 Nov 2025 · 22 likes The documentation on mass-error checker is better than this thread and I say that as someone who has posted in the thread.
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #38 · Analytics › Method validation · 8 Nov 2025 · 32 likes Confirming post #37 from a second method, which matters more than confirming it from a second person. Reframing Specificity slightly, because I think the disagreement…
Payment mechanics and the recovery options that do not exist Replied, post #85 · Sourcing › Payments · 22 Oct 2025 · 4 likes I had written a reply contradicting post #84 and deleted it. Here is what survived. Recording the time from payment to dispatch is worth doing, because it is the part…
The headache that turns out to be dehydration Replied, post #24 · Nutrition & Training › Hydration & electrolytes · 15 Oct 2025 · 0 likes I would be cautious about generalising from the headache example above. It is a good example. It is one example.
Reading a supplier's product description as a marketing document Replied, post #83 · Compounds › Other compounds · 13 Oct 2025 · 0 likes Narrowing post #82, because the general version has more than one answer. Solubility varies far more across this subcategory than within the incretins. A compound that…
Managing an unplanned gap in supply — what changed since Replied, post #83 · Access › Shortages · 9 Oct 2025 · 15 likes On Managing an unplanned gap: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #55 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 17 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #3 · Practice › Side effects · 22 Sep 2025 · 8 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Power cut for eleven hours: how I assessed it afterwards Replied, post #57 · Practice › Storage & stability · 14 Sep 2025 · 0 likes Temperature excursions in transit are common and are not all equal. A few hours warm is a different event from three days warm, and neither is visible in the vial on…
Batch date after test date, and other internal inconsistencies Started this topic · Analytics › COA interpretation · 7 Sep 2025 · 0 likes Batch date after test date, and other internal inconsistencies — setting out what I have, and where I think it stops being reliable. Proposing that batch date deserves…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #80 · Evidence › Journal club · 6 Sep 2025 · 0 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Revisiting: List price versus negotiated price versus what you pay Replied, post #22 · Access › Pricing · 9 Aug 2025 · 11 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Temperature loggers worth the money Replied, post #3 · Devices › Cold chain · 21 Jun 2025 · 1 like Everything in the opening post holds. The case it does not cover is the one I have. A temperature indicator that has tripped tells you a threshold was crossed. It does…
Triple agonism: additive, synergistic, or neither? Replied, post #59 · Compounds › Retatrutide · 21 Jun 2025 · 0 likes Counterpoint on triple agonism, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Washout: how long is long enough, and for what purpose Replied, post #35 · Pharmacology › Pharmacokinetics · 13 Jun 2025 · 7 likes Understood, and I withdraw the assumption I opened with.
Asking about a compound your prescriber has not heard of Replied, post #64 · Clinical › Prescriber conversations · 12 Jun 2025 · 0 likes Asking what would change the plan is more productive than asking whether the plan is right. It gets you the decision criteria rather than a verdict. That is the honest…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #4 · Compounds › Secretagogues & GH axis · 3 May 2025 · 8 likes Having read the whole reading a rodent study thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
Antibiotics and a course of something with delayed emptying Replied, post #9 · Practice › Interactions · 25 Mar 2025 · 11 likes Good question, well framed, and I would like to see it answered properly.
Charge states for a 4 kDa peptide, worked through Replied, post #125 · Analytics › Mass spectrometry · 16 Mar 2025 · 20 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #34 · Clinical › Comorbidities · 15 Mar 2025 · 5 likes That is a fair summary of where the discussion has got to.
Charge states for a 4 kDa peptide, worked through Replied, post #43 · Analytics › Mass spectrometry · 7 Mar 2025 · 30 likes Charge states is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #17 · Compounds › Other compounds · 30 Jan 2025 · 5 likes Taking post #14 at face value and following it one step further. How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data…
What changed in 2026, by region Replied, post #88 · Access › International · 20 Jan 2025 · 26 likes This is the first time the answer has come with its own limits attached. Appreciated.
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #22 · Evidence › Journal club · 6 Jan 2025 · 0 likes Taking post #21 at face value and following it one step further. Where I have landed on STEP 4, having got it wrong once in public: the direction is clear, the…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #79 · Evidence › Journal club · 2 Jan 2025 · 7 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #48 · Compounds › Semaglutide · 27 Dec 2024 · 8 likes Post #46 describes the usual case. This is about the unusual one. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with…
Converting between mg/mL and units per dose, both directions Replied, post #136 · Practice › Reconstitution · 19 Dec 2024 · 0 likes Coming back to post #132, because the follow-up matters more than the original answer. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear,…
Hello from a laboratory that does not do peptides — does this still hold? Replied, post #4 · Lounge › Introductions · 17 Dec 2024 · 11 likes Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people.
What would change my mind about repair peptides: a specific answer — one year on Replied, post #4 · Compounds › Repair & healing peptides · 29 Oct 2024 · 0 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
US compounding rules and how they changed Replied, post #25 · Regional › North America · 15 Oct 2024 · 0 likes Compounded preparations and authorised products are different regulatory categories with different oversight, and conflating them produces most of the confusion here.…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #80 · Clinical › Bloodwork · 4 Oct 2024 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. I am…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #27 · Practice › Administration · 13 Sep 2024 · 3 likes Answering the question post #25 raises rather than the one it answers. Note the site alongside the dose. If a local reaction appears three weeks later you will want to…
Correlation in a self-tracked dataset: what it can support Replied, post #154 · Research Methods › Statistics · 26 Aug 2024 · 27 likes Filing a mild objection to the consensus on correlation. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
Chronic kidney disease and the FLOW result Replied, post #2 · Clinical › Comorbidities · 8 Aug 2024 · 7 likes Answering the question the opening post raises rather than the one it answers. Where two conditions pull in opposite directions, that is a clinical judgement rather…